Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.9300 (-4.25%) ($10.9300 - $10.9300) on Tue. Dec. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.73% (three month average) | RSI | 52 | Latest Price | $10.9300(-4.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(19%) URA(17%) BLOK(16%) XLK(16%) VUG(14%) | Factors Impacting BCRX price | BCRX will decline at least -1.865% in a week (0% probabilities). SMH(-29%) ARKG(-24%) SHY(-9%) GLD(-9%) BWX(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.865% (StdDev 3.73%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.3 | 5 Day Moving Average | $11(-0.64%) | 10 Day Moving Average | $10.97(-0.36%) | 20 Day Moving Average | $11.3(-3.27%) | To recent high | -23.1% | To recent low | 4.4% | Market Cap | $1.928b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |